A descriptive evaluation of routine complete blood count monitoring in patients receiving anticoagulation therapy

Journal of Thrombosis and Thrombolysis

Volumn 20, Issue 3, 2005, Pages 183-188

  Anich, Kandace V ^a   Witt, Daniel M ^b,d   Delate, Thomas ^c   Shanahan, Roberta L ^a   Patel, Rachana J ^a  

^a Primary Care Clinical Pharmacy Services   (United States)

^b Kaiser Permanente of Colorado   (United States)

^c Kaiser Permanente of Colorado   (United States)

^d FCCP   (United States)

Author keywords

Abnormal; Blood cell count; Hematologic tests; Hemoglobins; Hemorrhage; Pharmacists; Warfarin

Indexed keywords

HEMOGLOBIN; WARFARIN;

ADULT; AGED; AGING; ARTICLE; BLEEDING; BLOOD CELL COUNT; BLOOD EXAMINATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART FAILURE; HEMOGLOBIN DETERMINATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OCCULT BLOOD; OUTCOMES RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; THROMBOPHILIA;

AGED; ANTICOAGULANTS; BLOOD CELL COUNT; CASE-CONTROL STUDIES; FEMALE; HEMOGLOBINS; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; RETROSPECTIVE STUDIES; WARFARIN;

EID: 27944442046     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-005-3842-8     Document Type: Article

References (11)

1. Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S. Hemorrhagic complications of anticoagulant therapy. CHEST 2004;126:287S-310S. 10.1378/chest.126.3_suppl.287S
2. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists. CHEST 2004;126:240S-233S. 10.1378/chest.126.3_suppl.204S
3. McCall KL, MacLaughlin EJ. Warfarin-associated bleeding complication saved life. Pharmacother 2002;22:265-268. 10.1592/phco.22.3.265.33554
4. Norton SA, Armstrong CP. Lower gastrointestinal bleeding during anticoagulant therapy: A life-saving complication? Ann Royal Col Surg Eng 1997;79:38-39.
5. Witt DM, Sadler MA, Shanahan R, Mazzoli G, Tillman TJ. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. CHEST 2005;127:1515-1522. 10.1378/ chest.127.5.1515
6. Sniderman AD. Is there value in liver function test and creatine phosphokinase monitoring with statin use? Am J Cardiol. 2004;94(9A):30F-34F. 10.1016/j.amjcard.2004.07.052
7. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Eng J Med 1996;335:407-416. 10.1056/NEJM199608083350607
8. Baker WF, Bick RL. Treatment of hereditary and acquired thrombophilic disorders. Sem Thromb Hemostasis 1999;25:387-406.
9. Beyth RJ, Quinn L, Landefeld CS. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin: A randomized, controlled trial. Ann Intern Med 2000;133:687-695. 11074901
10. Wells PS, Forgie MA, Simms M et al. The outpatient bleeding risk index: Validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism. Arch Intern Med 2003;163:917-920. 10.1001/archinte.163.8.917
11. Kuijer PMM, Hutten BA, Prins MH, Buller HR. Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. Arch Intern Med 1999;159:457-460. 10.1001/archinte.159.5.457